SynthesisFrontiers in pediatrics2026
Psychological impact and quality of life in pediatric patients with chronic skin disorders: a systematic review (2010-2025).
Synthesis in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic skin disorders in children and adolescents are increasingly recognized as conditions with significant psychosocial implications. Beyond physical manifestations, these diseases adversely affect psychological well-being, health-related quality of life (HRQoL), and family functioning. Methods: A systematic review was conducted following PRISMA guidelines. Five electronic databases were searched for studies published between 2010 and 2025. Empirical studies assessing psychological outcomes or HRQoL among pediatric patients (≤18 years) with chronic dermatologic conditions were included. Methodological quality was appraised using JBI and CASP tools. Due to heterogeneity in study designs and outcome measures, findings were synthesized narratively. Results: A total of 1,844 records were identified, with 41 studies meeting inclusion criteria. Most studies were cross-sectional (approximately 75%), with 12 classified as high methodological quality. Sample sizes ranged from fewer than 10 to over 11,000 children. Across conditions including atopic dermatitis, psoriasis, vitiligo, alopecia areata, hidradenitis suppurativa, and congenital ichthyosis, elevated rates of anxiety, depression, stigma, and emotional distress were consistently reported. Severe atopic dermatitis was associated with nearly a two-fold increased risk of depressive and internalizing symptoms in longitudinal data. HRQoL impairment commonly affected emotional functioning, peer relationships, school participation, and sleep. Caregiver burden was documented in 19 studies. Discussion: Findings highlight the multidimensional burden of pediatric chronic skin disease, where psychosocial distress often parallels physical symptom severity. Conclusion: Chronic skin disorders are consistently associated with psychological distress and reduced HRQoL. Causal inferences cannot be drawn given cross-sectional designs; findings support routine psychosocial assessment and family-centered care to improve outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.